By Crispin Dowler2015-12-18T12:43:00
NHS England’s chief financial officer has warned the board of a “substantial risk” that costs will ”significantly” outstrip the budget he has set for specialised commissioning next year, due to an ‘unprecedented stream’ of new and expensive drugs and treatments.
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud